Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis.

IF 3.5 4区医学 Q1 DERMATOLOGY

International Journal of Dermatology Pub Date : 2025-04-16 DOI:10.1111/ijd.17742

Jun Ting Tang, Ming Yuan Xu, Nan Hui Wu, Fei Wu, Ye Qiang Liu

引用次数: 0

查看原文本刊更多论文

酪氨酸激酶2抑制剂Deucravacitinib对重叠型银屑病和特应性皮炎的快速临床改善。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Dermatology 医学-皮肤病学

CiteScore

4.70

自引率

2.80%

发文量

476

审稿时长

3 months

期刊介绍： Published monthly, the International Journal of Dermatology is specifically designed to provide dermatologists around the world with a regular, up-to-date source of information on all aspects of the diagnosis and management of skin diseases. Accepted articles regularly cover clinical trials; education; morphology; pharmacology and therapeutics; case reports, and reviews. Additional features include tropical medical reports, news, correspondence, proceedings and transactions, and education. The International Journal of Dermatology is guided by a distinguished, international editorial board and emphasizes a global approach to continuing medical education for physicians and other providers of health care with a specific interest in problems relating to the skin.